• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection.

作者信息

Reuken Philipp A, Stallmach Andreas, Pletz Mathias W, Brandt Christian, Andreas Nico, Hahnfeld Sabine, Löffler Bettina, Baumgart Sabine, Kamradt Thomas, Bauer Michael

机构信息

Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany.

Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.

出版信息

Leukemia. 2021 Mar;35(3):920-923. doi: 10.1038/s41375-021-01175-8. Epub 2021 Feb 19.

DOI:10.1038/s41375-021-01175-8
PMID:33608636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893131/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7445/7932920/8ee860db235d/41375_2021_1175_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7445/7932920/2c0ba5a5bcc9/41375_2021_1175_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7445/7932920/8ee860db235d/41375_2021_1175_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7445/7932920/2c0ba5a5bcc9/41375_2021_1175_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7445/7932920/8ee860db235d/41375_2021_1175_Fig2_HTML.jpg

相似文献

1
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection.免疫功能低下宿主中持续性严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）感染导致的严重临床复发
Leukemia. 2021 Mar;35(3):920-923. doi: 10.1038/s41375-021-01175-8. Epub 2021 Feb 19.
2
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma.滤泡性淋巴瘤患者持续性 SARS-CoV-2 感染的管理。
Acta Haematol. 2022;145(4):384-393. doi: 10.1159/000521121. Epub 2021 Nov 26.
3
Janus-faced course of COVID-19 infection in patients with hematological malignancies.血液系统恶性肿瘤患者中COVID-19感染的双面病程。
Eur J Haematol. 2020 Oct;105(4):502-504. doi: 10.1111/ejh.13470. Epub 2020 Jul 2.
4
Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma.免疫功能低下患者在接受奥滨尤妥珠单抗联合苯达莫司汀治疗滤泡性淋巴瘤后出现持续 COVID-19。
Intern Med. 2022 Aug 15;61(16):2523-2526. doi: 10.2169/internalmedicine.9136-21. Epub 2022 May 31.
5
A Case of Long-Term SARS-CoV-2 Infection in a Patient with Follicular Lymphoma.1例滤泡性淋巴瘤患者的长期新冠病毒感染病例
Clin Lab. 2024 May 1;70(5). doi: 10.7754/Clin.Lab.2023.231221.
6
Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections.滤泡性淋巴瘤患者在接受利妥昔单抗维持治疗后一年持续的 COVID-19 肺炎缓解和免疫性血小板减少症的发生：一例长期感染病例的随访报告及文献复习
Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):e810-e816. doi: 10.1016/j.clml.2021.07.004. Epub 2021 Jul 18.
7
Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series.滤泡性淋巴瘤患者感染 SARS-CoV-2 后反复和持续发热：病例系列。
Int J Infect Dis. 2024 Apr;141:106973. doi: 10.1016/j.ijid.2024.02.016. Epub 2024 Feb 21.
8
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.两例滤泡性淋巴瘤患者在接受苯达莫司汀和奥滨尤妥珠单抗或利妥昔单抗治疗后出现持续性 SARS-CoV-2 感染和多次临床复发。
Infection. 2023 Oct;51(5):1577-1581. doi: 10.1007/s15010-023-02039-2. Epub 2023 Apr 19.
9
Heterologous SARS-CoV-2 vaccinations in patients with B-cell lymphoid malignancies.B细胞淋巴恶性肿瘤患者的异源严重急性呼吸综合征冠状病毒2疫苗接种
Am J Hematol. 2022 Feb 1;97(2):E67-E69. doi: 10.1002/ajh.26418. Epub 2021 Nov 30.
10
Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection.辅助性病毒细胞培养有助于指导继发体液免疫缺陷和持续感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）患者的治疗决策。
Br J Haematol. 2022 Mar;196(5):1170-1174. doi: 10.1111/bjh.17957. Epub 2021 Nov 11.

引用本文的文献

1
A Systematic Review of Prolonged SARS-CoV-2 Shedding in Immunocompromised Persons.免疫功能低下人群中新冠病毒长期排毒的系统评价
Influenza Other Respir Viruses. 2025 May;19(5):e70121. doi: 10.1111/irv.70121.
2
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients.免疫功能低下患者体内 SARS-CoV-2 的长时间感染过程中的进化。
mBio. 2024 Mar 13;15(3):e0011024. doi: 10.1128/mbio.00110-24. Epub 2024 Feb 16.
3
Exploring Peripheral Blood-Derived Extracellular Vesicles as Biomarkers: Implications for Chronic Chagas Disease with Viral Infection or Transplantation.

本文引用的文献

1
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
2
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.针对 SARS-CoV-2 受体结合域的特异性体液免疫反应受损与病毒在胃肠道内的持续存在和周期性脱落有关。
Cell Mol Immunol. 2020 Nov;17(11):1119-1125. doi: 10.1038/s41423-020-00550-2. Epub 2020 Oct 9.
3
Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
探索外周血来源的细胞外囊泡作为生物标志物：对合并病毒感染或移植的慢性恰加斯病的意义
Microorganisms. 2024 Jan 5;12(1):116. doi: 10.3390/microorganisms12010116.
4
SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing.免疫功能低下宿主中的 SARS-CoV-2：通过全基因组测序阐明恢复期血浆治疗和病毒进化。
BMJ Case Rep. 2023 Dec 9;16(12):e255255. doi: 10.1136/bcr-2023-255255.
5
A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma.一个教学案例：一名缓解期淋巴瘤患者出现类似隐源性机化性肺炎的持续性新冠肺炎肺炎。
Cureus. 2023 Nov 5;15(11):e48319. doi: 10.7759/cureus.48319. eCollection 2023 Nov.
6
Post-COVID-More than chronic fatigue?新冠后-不仅仅是慢性疲劳？
Herz. 2023 Jun;48(3):229-233. doi: 10.1007/s00059-023-05170-w. Epub 2023 Apr 27.
7
Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity.长新冠：对新冠病毒感染临床后果的叙述性综述，重点关注假定的病理生理学和身体活动方面。
Oxf Open Immunol. 2022 Sep 16;3(1):iqac006. doi: 10.1093/oxfimm/iqac006. eCollection 2022.
8
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants.宿主内进化导致了 SARS-CoV-2 变体的持续出现。
mBio. 2023 Apr 25;14(2):e0344822. doi: 10.1128/mbio.03448-22. Epub 2023 Feb 14.
9
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.COVID-19 恢复期血浆治疗免疫功能低下患者：系统评价和荟萃分析。
JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647.
10
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?恢复期 COVID-19 患者调节性 T 细胞动态的范围综述——提示其可能参与长新冠的发生？
Front Immunol. 2022 Dec 13;13:1070994. doi: 10.3389/fimmu.2022.1070994. eCollection 2022.
慢性淋巴细胞白血病患者的抗严重急性呼吸综合征冠状病毒2抗体反应
Leukemia. 2020 Nov;34(11):3047-3049. doi: 10.1038/s41375-020-01030-2. Epub 2020 Aug 27.
4
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.一种用于 SARS-CoV-2 谱系的动态命名建议，以辅助基因组流行病学研究。
Nat Microbiol. 2020 Nov;5(11):1403-1407. doi: 10.1038/s41564-020-0770-5. Epub 2020 Jul 15.
5
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
6
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.感染新型冠状病毒肺炎的血液病患者的临床特征与转归：意大利、西班牙和荷兰四家医院的一项回顾性病例研究
Leukemia. 2020 Sep;34(9):2536-2538. doi: 10.1038/s41375-020-0960-4. Epub 2020 Jul 8.
7
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. 关于癌症患者中 SARS-CoV-2 的常见问题解答——为照顾恶性疾病患者的临床医生提供的建议。
Leukemia. 2020 Jun;34(6):1487-1494. doi: 10.1038/s41375-020-0832-y. Epub 2020 May 1.
8
Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.SARS-CoV-2 的进化史、潜在的中间宿主动物及种间分析。
J Med Virol. 2020 Jun;92(6):602-611. doi: 10.1002/jmv.25731. Epub 2020 Mar 11.
9
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia.viSNE 能够可视化高维单细胞数据，并揭示白血病的表型异质性。
Nat Biotechnol. 2013 Jun;31(6):545-52. doi: 10.1038/nbt.2594. Epub 2013 May 19.
10
Moderate mutation rate in the SARS coronavirus genome and its implications.严重急性呼吸综合征冠状病毒基因组中的适度突变率及其影响
BMC Evol Biol. 2004 Jun 28;4:21. doi: 10.1186/1471-2148-4-21.